UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 633

Sortiert nach

Liberté surveillée: Supervision bancaire et globalisation financière au Comité de Bâle, 1974-1988

Drach, Alexis

2022

Volltextzugriff (PDF)

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Leukemia, 2009-12, Vol.23 (12), p.2210-2221

2009

Volltextzugriff (PDF)

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

Leukemia, 2017-01, Vol.31 (1), p.107-114

2017

Volltextzugriff (PDF)

Bortezomib Administered Subcutaneously Is Well Tolerated in Bortezomib-Based Combination Regimens Used in Patients with Multiple Myeloma

Oncology, 2013-11, Vol.85 (4), p.223-227

2013

Volltextzugriff (PDF)

Final overall survival results of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) vs R-CHOP in transplantation-ineligible patients (pts) with newly diagnosed mantle-cell lymphoma (MCL): A randomized, open-label, phase III (LYM-3002) study

Annals of oncology, 2018-10, Vol.29, p.viii359-viii359

2018

Volltextzugriff (PDF)

Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis

Annals of hematology, 2011-02, Vol.90 (2), p.201-206

2011

Volltextzugriff (PDF)

Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma

Blood, 2004-10, Vol.104 (8), p.2269-2271

2004

Volltextzugriff (PDF)

Design, Synthesis, and Antiviral Evaluations of 1-(Substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as Nonnucleoside Analogues of 2,5,6-Trichloro-1-(β-d-ribofuranosyl)benzimidazole

Journal of medicinal chemistry, 1998-04, Vol.41 (8), p.1252-1262

1998

Volltextzugriff (PDF)

Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion

Leukemia, 2007-01, Vol.21 (1), p.164-168

2007

Volltextzugriff (PDF)

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l-Riboside with a Unique Mode of Action

Antimicrobial Agents and Chemotherapy, 2002-08, Vol.46 (8), p.2365-2372

2002

Volltextzugriff (PDF)

Synthesis and Antiviral Activity of Novel Erythrofuranosyl Imidazo[1,2-a]pyridine C-Nucleosides Constructed via Palladium Coupling of Iodoimidazo[1,2-a]pyridines and Dihydrofuran

Journal of medicinal chemistry, 2003-04, Vol.46 (8), p.1449-1455

2003

Volltextzugriff (PDF)

Design, Synthesis, and Antiviral Activity of α-Nucleosides: d- and l-Isomers of Lyxofuranosyl- and (5-Deoxylyxofuranosyl)benzimidazoles

Journal of medicinal chemistry, 1998-04, Vol.41 (8), p.1242-1251

1998

Volltextzugriff (PDF)

Zytogenetik und Molekularzytogenetik des multiplen Myeloms

Der Onkologe, 2010-03, Vol.16 (3), p.252-262

2010

Volltextzugriff (PDF)

Biologie des multiplen Myeloms

Der Onkologe, 2004-08, Vol.10 (8), p.801-808

Drach, J.

2004

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Tricyclic Nucleosides (Dimensional Probes) as Analogues of Certain Antiviral Polyhalogenated Benzimidazole Ribonucleosides

Journal of medicinal chemistry, 2000-06, Vol.43 (12), p.2430-2437

2000

Volltextzugriff (PDF)

Amino Acid Ester Prodrugs of the Antiviral Agent 2-Bromo-5,6-dichloro-1-(β-d-ribofuranosyl)benzimidazole as Potential Substrates of hPEPT1 Transporter

Journal of medicinal chemistry, 2005-02, Vol.48 (4), p.1274-1277

2005

Volltextzugriff (PDF)

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma

Annals of oncology, 2004-07, Vol.15 (7), p.1086-1090

2004

Volltextzugriff (PDF)

In Vitro Activities of Benzimidazole d- and l-Ribonucleosides against Herpesviruses

Antimicrobial Agents and Chemotherapy, 2003-07, Vol.47 (7), p.2186-2192

2003

Volltextzugriff (PDF)

Subpopulations of Normal Peripheral Blood and Bone Marrow Cells Express a Functional Multidrug Resistant Phenotype

Blood, 1992-12, Vol.80 (11), p.2729-2734

1992

Volltextzugriff (PDF)

Synthesis and Antiviral Evaluation of Trisubstituted Indole N-Nucleosides as Analogues of 2,5,6-Trichloro-1-(β-d-ribofuranosyl)benzimidazole (TCRB)

Journal of medicinal chemistry, 2000-06, Vol.43 (12), p.2449-2456

2000

Volltextzugriff (PDF)

Expression of MUM1 IRF4 mRNA as a prognostic marker in patients with multiple myeloma

Leukemia, 2008-02, Vol.22 (2), p.441-445

2008

Volltextzugriff (PDF)

(Z)- and (E)-2-((Hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New Nucleoside Analogues with a Broad-Spectrum Antiviral Activity

Journal of medicinal chemistry, 1998-01, Vol.41 (1), p.10-23

1998

Volltextzugriff (PDF)

Resistance of Human Cytomegalovirus to the Benzimidazole l-Ribonucleoside Maribavir Maps to UL27

Journal of Virology, 2003-11, Vol.77 (21), p.11499-11506

2003

Volltextzugriff (PDF)

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP)

Annals of oncology, 2003-12, Vol.14 (12), p.1758-1761

2003

Volltextzugriff (PDF)

Synthesis and Antiviral Evaluation of Halogenated β-d- and -l-Erythrofuranosylbenzimidazoles

Journal of medicinal chemistry, 2000-06, Vol.43 (12), p.2464-2472

2000

Volltextzugriff (PDF)

1 – 25 von 633

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(494)
Mit Volltextzugriff
(530)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(389)
Life Sciences & Biomedicine
(324)
Humans
(278)
Biological And Medical Sciences
(194)
Medical Sciences
(181)
Male
(104)
Female
(101)
Pharmacology & Pharmacy
(92)
Antiviral Agents - Pharmacology
(88)
Middle Aged
(88)
Aged
(87)
Animals
(86)
Pharmacology. Drug Treatments
(85)
Cytomegalovirus - Drug Effects
(78)
Antiviral Agents
(68)
Oncology
(68)
Antiviral Agents - Chemical Synthesis
(67)
Adult
(65)
Hematology
(65)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(64)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Medicinal Chemistry
(58)
Cheminform
(41)
The Journal Of Urology
(27)
Antimicrobial Agents And Chemotherapy
(21)
Antiviral Research
(21)
Blood
(21)
Nucleosides, Nucleotides & Nucleic Acids
(18)
Leukemia
(13)
Nucleosides & Nucleotides
(13)
British Journal Of Haematology
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Liberté surveillée: Supervision bancaire et globalisation financière au Comité de Bâle, 1974-1988

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

Bortezomib Administered Subcutaneously Is Well Tolerated in Bortezomib-Based Combination Regimens Used in Patients with Multiple Myeloma

Final overall survival results of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) vs R-CHOP in transplantation-ineligible patients (pts) with newly diagnosed mantle-cell lymphoma (MCL): A randomized, open-label, phase III (LYM-3002) study

Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis

Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma

Design, Synthesis, and Antiviral Evaluations of 1-(Substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as Nonnucleoside Analogues of 2,5,6-Trichloro-1-(β-d-ribofuranosyl)benzimidazole

Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l-Riboside with a Unique Mode of Action

Synthesis and Antiviral Activity of Novel Erythrofuranosyl Imidazo[1,2-a]pyridine C-Nucleosides Constructed via Palladium Coupling of Iodoimidazo[1,2-a]pyridines and Dihydrofuran

Design, Synthesis, and Antiviral Activity of α-Nucleosides: d- and l-Isomers of Lyxofuranosyl- and (5-Deoxylyxofuranosyl)benzimidazoles

Zytogenetik und Molekularzytogenetik des multiplen Myeloms

Biologie des multiplen Myeloms

Design, Synthesis, and Biological Evaluation of Tricyclic Nucleosides (Dimensional Probes) as Analogues of Certain Antiviral Polyhalogenated Benzimidazole Ribonucleosides

Amino Acid Ester Prodrugs of the Antiviral Agent 2-Bromo-5,6-dichloro-1-(β-d-ribofuranosyl)benzimidazole as Potential Substrates of hPEPT1 Transporter

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma

In Vitro Activities of Benzimidazole d- and l-Ribonucleosides against Herpesviruses

Subpopulations of Normal Peripheral Blood and Bone Marrow Cells Express a Functional Multidrug Resistant Phenotype

Synthesis and Antiviral Evaluation of Trisubstituted Indole N-Nucleosides as Analogues of 2,5,6-Trichloro-1-(β-d-ribofuranosyl)benzimidazole (TCRB)

Expression of MUM1 IRF4 mRNA as a prognostic marker in patients with multiple myeloma

(Z)- and (E)-2-((Hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New Nucleoside Analogues with a Broad-Spectrum Antiviral Activity

Resistance of Human Cytomegalovirus to the Benzimidazole l-Ribonucleoside Maribavir Maps to UL27

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP)

Synthesis and Antiviral Evaluation of Halogenated β-d- and -l-Erythrofuranosylbenzimidazoles

Suchergebnisse filtern